Home
Scholarly Works
Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) in...
Conference

Nivolumab (Anti-PD-1; BMS-936558, ONO-4538) in Combination With Platinum-Based Doublet Chemotherapy (PT-DC) in Advanced Non-Small Cell Lung Cancer (NSCLC) Metastatic Non-Small Cell Lung Cancer

Authors

Antonia SJ; Brahmer JR; Gettinger S; Chow LQ; Juergens R; Shepherd FA; Laurie SA; Gerber DE; Goldman J; Shen Y

Volume

90

Publisher

Elsevier

Publication Date

November 15, 2014

DOI

10.1016/j.ijrobp.2014.08.024

Conference proceedings

International Journal of Radiation Oncology • Biology • Physics

Issue

5

ISSN

0360-3016

Contact the Experts team